NCT03611556 2023-10-03MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.MedImmune LLCPhase 1/2 Completed213 enrolled 42 charts
NCT03221400 2022-02-17PEN-866 in Patients With Advanced Solid MalignanciesTarveda TherapeuticsPhase 1/2 Unknown340 enrolled